Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Clinical trial NCT06190249 · WITHDRAWN

Trial details

NCT number: NCT06190249
Sponsor: James Isaacs, MD
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IIIB Melanoma Stage IIIC Melanoma Stage IIID Melanoma

Start date: 2024-12-02
Primary completion: 2028-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.